Michel Detheux's most recent trade in ITeos Therapeutics Inc was a trade of 94,027 Common Stock done at an average price of $4.3 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 09 Jun 2025 | 94,027 | 94,027 | - | 4.3 | 404,316 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 94,027 | 3 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 09 Jun 2025 | 43,883 | 0 | - | 10.0 | 439,708 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 09 Jun 2025 | 43,883 | 43,883 | - | 4.3 | 188,697 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 43,883 | 94,030 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 43,882 | 137,913 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 09 Jun 2025 | 43,882 | 0 | - | 10.0 | 440,136 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 09 Jun 2025 | 43,882 | 43,882 | - | 4.3 | 188,693 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 09 Jun 2025 | 18,000 | 153,903 | - | 4.3 | 77,400 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 18,000 | 0 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 8,400 | 26,400 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 09 Jun 2025 | 8,400 | 135,903 | - | 10.0 | 84,168 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 09 Jun 2025 | 8,400 | 144,303 | - | 4.3 | 36,120 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 8,400 | 18,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 09 Jun 2025 | 8,400 | 144,303 | - | 4.3 | 36,120 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 09 Jun 2025 | 8,400 | 135,903 | - | 10.0 | 84,252 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 43,883 | 269,559 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 43,883 | 43,883 | - | 4.3 | 188,697 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 04 Jun 2025 | 43,883 | 0 | - | 10.1 | 443,218 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 43,882 | 43,882 | - | 4.3 | 188,693 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.15 per share. | 04 Jun 2025 | 43,882 | 0 | - | 10.1 | 445,402 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 43,882 | 43,882 | - | 4.3 | 188,693 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.21 per share. | 04 Jun 2025 | 43,882 | 0 | - | 10.2 | 448,035 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 43,882 | 225,677 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 43,882 | 181,795 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 8,400 | 144,303 | - | 4.3 | 36,120 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.21 per share. | 04 Jun 2025 | 8,400 | 135,903 | - | 10.2 | 85,764 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 8,400 | 51,600 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 8,400 | 43,200 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 8,400 | 34,800 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 8,400 | 144,303 | - | 4.3 | 36,120 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 04 Jun 2025 | 8,400 | 135,903 | - | 10.1 | 84,840 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 04 Jun 2025 | 8,400 | 144,303 | - | 4.3 | 36,120 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.15 per share. | 04 Jun 2025 | 8,400 | 135,903 | - | 10.2 | 85,260 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 459,000 | 459,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 77,000 | 135,903 | - | 0 | Common Stock | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2024 | 442,800 | 442,800 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2024 | 442,800 | 147,600 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 590,400 | 590,400 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 30,000 | 58,903 | - | 0 | Common Stock | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 346,000 | 346,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Mar 2023 | 254,997 | 91,003 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Mar 2023 | 254,997 | 254,997 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 264,375 | 88,125 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 264,375 | 264,375 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2022 | 11,500 | 144,464 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. | 18 Apr 2022 | 11,500 | 37,763 | - | 4.2 | 48,645 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.87 per share. | 18 Apr 2022 | 11,467 | 26,296 | - | 31.9 | 365,453 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.64 per share. | 18 Apr 2022 | 33 | 26,263 | - | 32.6 | 1,077 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.11 per share. | 21 Mar 2022 | 9,908 | 28,970 | - | 34.1 | 337,962 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 21 Mar 2022 | 5,822 | 38,878 | - | 33.4 | 194,688 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.51 per share. | 21 Mar 2022 | 1,548 | 26,263 | - | 36.5 | 56,517 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.22 per share. | 21 Mar 2022 | 1,159 | 27,811 | - | 35.2 | 40,820 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 352,500 | 352,500 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 10,000 | 44,700 | - | 0 | Common Stock | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.30 per share. | 23 Feb 2022 | 13,956 | 35,244 | - | 34.3 | 478,691 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.32 per share. | 23 Feb 2022 | 544 | 34,700 | - | 35.3 | 19,214 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.45 per share. | 25 Jan 2022 | 10,088 | 53,612 | - | 35.5 | 357,620 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.21 per share. | 25 Jan 2022 | 4,412 | 49,200 | - | 36.2 | 159,759 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 776,600 | 776,600 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 776,600 | 258,824 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 313,442 | 313,442 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 313,442 | 90,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 185,000 | 185,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 185,000 | 155,964 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 106,200 | 37,800 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 106,200 | 106,200 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 52,700 | 52,700 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 52,700 | 17,544 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 02 Dec 2021 | 19,226 | 97,426 | - | 4.3 | 82,672 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 19,226 | 61,663 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.15 per share. | 02 Dec 2021 | 13,646 | 83,780 | - | 44.2 | 602,471 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.37 per share. | 02 Dec 2021 | 9,493 | 63,700 | - | 45.4 | 430,697 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.94 per share. | 02 Dec 2021 | 9,111 | 78,200 | - | 43.9 | 400,337 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 02 Dec 2021 | 9,111 | 87,311 | - | 4.3 | 39,177 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 9,111 | 80,889 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 02 Dec 2021 | 5,580 | 78,200 | - | 45.1 | 251,435 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.62 per share. | 02 Dec 2021 | 5,007 | 73,193 | - | 44.6 | 223,412 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 02 Dec 2021 | 1,663 | 79,863 | - | 4.3 | 7,151 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 1,663 | 60,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.31 per share. | 02 Dec 2021 | 1,514 | 78,349 | - | 44.3 | 67,085 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.92 per share. | 02 Dec 2021 | 149 | 78,200 | - | 44.9 | 6,693 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 16,263 | 0 | - | - | Stock Option (right to buy) | |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.45 per share. | 22 Nov 2021 | 16,263 | 92,700 | - | 12.4 | 202,474 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.08 per share. | 22 Nov 2021 | 14,500 | 78,200 | - | 36.1 | 523,160 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.41 per share. | 01 Nov 2021 | 14,391 | 82,522 | - | 28.4 | 408,920 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.89 per share. | 01 Nov 2021 | 6,085 | 76,437 | - | 28.9 | 175,777 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 01 Nov 2021 | 81 | 96,913 | - | 28 | 2,268 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 21 Oct 2021 | 196 | 96,994 | - | 28 | 5,488 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 15 Oct 2021 | 1,635 | 97,391 | - | 28.0 | 45,796 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 15 Oct 2021 | 201 | 97,190 | - | 28 | 5,628 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.16 per share. | 23 Sep 2021 | 5,322 | 100,115 | - | 28.2 | 149,862 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.02 per share. | 23 Sep 2021 | 1,089 | 99,026 | - | 28.0 | 30,512 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.17 per share. | 27 Aug 2021 | 8,248 | 132,104 | - | 28.2 | 232,346 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 27 Aug 2021 | 4,093 | 125,689 | - | 28.1 | 115,095 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 27 Aug 2021 | 2,322 | 129,782 | - | 28.0 | 65,039 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.06 per share. | 23 Aug 2021 | 7,499 | 141,438 | - | 28.1 | 210,422 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 23 Aug 2021 | 861 | 140,352 | - | 28.0 | 24,109 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.26 per share. | 23 Aug 2021 | 225 | 141,213 | - | 28.3 | 6,359 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.38 per share. | 14 Jun 2021 | 25,063 | 152,874 | - | 28.4 | 711,336 | Common Stock |
| ITeos Therapeutics Inc | Michel Detheux | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.26 per share. | 14 Jun 2021 | 3,937 | 148,937 | - | 29.3 | 115,199 | Common Stock |